Tata Memorial Centre
Quick facts
Phase 3 pipeline
- Curcumin Lozenges · Oncology, Oral health, Anti-inflammatory
Curcumin, the active compound from turmeric, exerts anti-inflammatory and antioxidant effects by inhibiting NF-κB signaling and reducing pro-inflammatory cytokine production.
Phase 2 pipeline
- ADT for 2 years · Oncology
Androgen deprivation therapy (ADT) involves the use of medications to suppress the production of androgens, such as testosterone, which can fuel the growth of certain types of cancer. - ADT for 9 months and ARTA for 6 months · Oncology
Androgen deprivation therapy (ADT) involves blocking the production of androgens, such as testosterone, which fuel the growth of prostate cancer cells. Androgen receptor signaling inhibitor (ARTA) works by blocking the androgen receptor, preventing cancer cells from receiving the signals they need to grow and multiply. - Chlorophyllin · Other
- Chlorophyllin, Sodium Copper Complex
- Cisplatin based chemotherpay · Oncology
Cisplatin works by crosslinking DNA, thereby inhibiting DNA replication and transcription. - Sodium Copper Chlorophyllin
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Tata Memorial Centre
What is Tata Memorial Centre's pipeline?
Tata Memorial Centre has 1 drugs in Phase 3, 6 in Phase 2, 1 in Phase 1. Late-stage candidates include Curcumin Lozenges.
Related
- Sector hub: All tracked pharma companies